Results 291 to 300 of about 289,605 (341)

Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors

Advanced Science, EarlyView.
Schematic illustration of the “pro‐ATO”/allicin liposomal strategy. Liposomal encapsulation improves the stability and bioavailability of both agents while masking allicin's odor. Upon release in the tumor microenvironment, ATO reactivates structural p53 mutants, and allicin inhibits ATR signaling while releasing H2S, collectively inducing synthetic ...
Xiaoling Xu, WeiYi Cheng, Menghang Yang, Li He, WeiYe Ren, JingQuan Chen, LiTing He, Dandan Bao, Zhihong Zhu, Lixin Wang, Qinghua Yao, Ji‐Gang Piao   +11 more
wiley   +1 more source

NUSAP1 Recruits DAXX to Suppress HIF-Driven Triple-Negative Breast Cancer Progression. [PDF]

Adv Sci (Weinh)
Du Y, Wang J, Wang M, Zhang Y, Zheng M, Li H, Wang X, Sun H, Tang K, Shan C, Zhao Q, Meng X, Wang Y, Zhou J, Chen Y.   +14 more
europepmc   +1 more source

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, EarlyView.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

Monitoring Triple-Negative Breast Cancer with a Trop2-targeted Peptide PET Probe. [PDF]

Radiol Imaging Cancer
Edil BH, Agarwal H, Panneerselvam M, McNally LR.   +3 more
europepmc   +1 more source

Immunotherapy in Triple-Negative Breast Cancer. [PDF]

Oncol Ther
Tiberi E, Parisi A, Pistelli M, Savini A, Galassi F, Reschini C, Quintavalle D, Napoleoni R, Ferrari C, Berardi R.   +9 more
europepmc   +1 more source

Targeting SOX9: designing a novel vaccine against triple-negative breast cancer. [PDF]

Sci Rep
Hatamian G, Ebrahimpour A, Nejabat M, Hadizadeh F.   +3 more
europepmc   +1 more source

In silico design of a multi-epitope vaccine against the triple negative breast cancer. [PDF]

Sci Rep
Zahraei M, Roohparvar Basmenj E, Behrouzi G, Heidari Keshel S, Alem M.   +4 more
europepmc   +1 more source

Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer. [PDF]

J Exp Clin Cancer Res
Varadkar T, Zhou ZZ, Zhang J, Sarkar A, Du Z, Chowdhury S, Lim H, Zhou L, Liu XM.   +8 more
europepmc   +1 more source

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells

, 2016
Cook MT, Y Liang, C Besch-Williford, Hyder SM   +3 more
openalex   +1 more source